Nirvana Life Sciences Inc. (CSE:NIRV)
Canada · Delayed Price · Currency is CAD 0.0300
-0.0550 (-64.71%)
Sep 25, 2025, 9:05 AM EDT
-64.71% (1Y)
| Market Cap | 684.70K |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -346.30K |
| Shares Out | 22.82M |
| EPS (ttm) | -0.04 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 4,540 |
| Average Volume | 227 |
| Open | 0.0300 |
| Previous Close | 0.0850 |
| Day's Range | 0.0300 - 0.0300 |
| 52-Week Range | 0.0300 - 0.7500 |
| Beta | 0.22 |
| RSI | 4.73 |
| Earnings Date | Dec 9, 2025 |